arrow_back Back to App

Designating National Ataxia Awareness Day to Boost Research and Care.

The U.S. Senate designated September 25th as National Ataxia Awareness Day. This resolution aims to increase public and professional knowledge about Ataxia, a rare neurodegenerative disease causing severe coordination issues. The designation supports improving diagnosis, ensuring better access to care for affected individuals, and accelerating clinical research to find effective treatments and a cure.
Key points
Official designation of September 25th to raise public awareness of Ataxia, a rare neurological disorder affecting coordination.
Support for patients and families by promoting better diagnosis and access to necessary medical care and therapies.
Encouragement for accelerating clinical research efforts aimed at finding treatments and ultimately a cure for this progressive disease.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_507
Sponsor: Sen. Hyde-Smith, Cindy [R-MS]
Process start date: 2023-12-14
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating September 25, 2023, as "National Ataxia Awareness Day", and raising awareness of ataxia, ataxia research, and the search for a cure.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_507.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-12-14.

What are the main provisions?

Key points include:

  • Official designation of September 25th to raise public awareness of Ataxia, a rare neurological disorder affecting coordination.
  • Support for patients and families by promoting better diagnosis and access to necessary medical care and therapies.
  • Encouragement for accelerating clinical research efforts aimed at finding treatments and ultimately a cure for this progressive disease.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hyde-Smith, Cindy [R-MS].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6011; text: CR S6002-6003)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health